Insider · CIK 0001515709
Nicholas C Gangestad
Files at NUE (NUCOR CORP), G (Genpact LTD), AMRZ (Amrize Ltd). First filing May 14, 2025, latest Nov 20, 2025.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
AMRZ: Amrize Ltd
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
G: Genpact LTD
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | AMRZbuy Amrize Ltd | $95k 2,000 shares | +68% | +2% from low-15% from high | |
| 36Weak | Gbuy Genpact LTD | $88k 2,000 shares | - | +15% from low-21% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 19, 2025 | AMRZ Amrize Ltd | POpen-market purchase Ordinary Shares | +2,000 | $47.34 | $95k | 4,958 | Nov 20, 2025 |
| Aug 11, 2025 | AMRZ Amrize Ltd | AGrant or award Ordinary Shares | +2,958 | $0.00 | $0 | 2,958 | Aug 13, 2025 |
| Jun 30, 2025 | G Genpact LTD | AGrant or award Common Shares | +1,988 | $0.00 | $0 | 8,813 | Jul 2, 2025 |
| Jun 1, 2025 | NUE NUCOR CORP | AGrant or award Common Stock | +1,554 | $0.00 | $0 | 3,560 | Jun 3, 2025 |
| May 22, 2025 | G Genpact LTD | AGrant or award Common Shares | +4,825 | $0.00 | $0 | 6,825 | May 27, 2025 |
| May 13, 2025 | G Genpact LTD | POpen-market purchase Common Shares | +2,000 | $43.97 | $88k | 2,000 | May 14, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.